Header Logo

Connection

LUCAS WONG to Bevacizumab

Back to Details
This is a "connection" page, showing publications LUCAS WONG has written about Bevacizumab.
LUCAS WONG
Connection Strength
0.019
Bevacizumab
  1. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study. J Clin Oncol. 2008 Jul 20; 26(21):3523-9.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.